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Kearns-Sayre syndrome is a mitochondrial myopathy, which was first described 
by Tomas Kearn in 1958. Diagnostic symptoms include retinitis pigmentosa, 
chronic and progressive external ophthalmoplegia plus one or more of following 
factors: heart conduction system disorders, cerebellar ataxia, or cerebrospinal 
fluid (CSF) protein content above 100 mg/dL. The nature of this uncommon 
disease is yet to be clarified. In this paper, we report a case of Kearns-Sayre 
syndrome. According to the previous records, the first manifestation of Kearns-
Sayre syndrome as hypoparathyroidism is uncommon and in this article, we 
report a case with this problem.
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CASE REPORT
Introduction
Kearns-Sayre syndrome is diagnosed with chronic and progressive external 
ophthalmoplegia (CPEO) and retinitis pigmentosa onset before the age of 20. 
Clinical features are often associated with cerebellar ataxia, cardiac conduction 
block, elevated protein content of cerebrospinal fluid (CSF), and proximal 
myopathy. Children with Kearns-Sayre syndrome suffer from short stature and 
often endocrinopathies, including diabetes, parathyroid dysfunction, and Addison’s 
disease. Renal tubular acidosis (proximal and distal) exists in several cases, which 
is associated with renal failure and also bilateral hearing loss (1).
Other symptoms may include:
1. Muscle weakness
a. Chronic and progressive loss of eye movements and ptosis
b. Dysphagia
 skeletal muscle weakness (proximal more than distal), and exercise intolerance
2. CNS disorders
c. Cerebellar ataxia




5. Heart disease (conduction disorders, congestive heart failure, and cardiomyopathy)
6. Endocrine disorders (diabetes, menstrual irregularities, delayed puberty, poor 
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Fig 1. Bilateral ptosis
According to ophthalmology consultation, sight in 
both eyes was estimated around 2/10 with a maximum 
correction and bilateral severe dysfunction of eyelids 
and ptosis due to myopathy, probably Kearns-Sayre 
syndrome, CPEO, and bilateral retinal pigmentary 
changes with scar. In cases with severe eyelid 
impairment and ptosis, surgery may be needed.
Carotid doppler sonography was normal and abdominal 
ultrasound showed increased renal echogenicity, but 
DMSA scan was normal. Electromyography (EMG) 
and nerve conduction velocity (NCV) implicated in 
myopathic process with negative results in Jouly test.
The assessments for autoimmune diseases, including 
anti TPO (thyroid peroxidase) antibody for thyroid 
assessment and anti TTG (tissue transglutaminase) 
antibody  for celiac disease revealed no significant 
finding. Measurement of aldosterone and renin activity
revealed normal  results. In ACTH (adrenocorticotropin 
hormone) stimulation test, cortisol level was normal. 
Cell blood count (CBC) and Urin alysis were normal. 
Liver function tests, alkaline phosphatase, urea, and 
creatinine were within normal limits. Calcium was 
between 9.8 and 10.1 mg/dL, while she was under 
treatment for hypoparathyroidism. Hemoglobin 
A1C level was in the high range, which showed the 
improper control of diabetes. Genetic evaluation was 
not performed due to the lack of financial sources.
In the Figure 2, the patient’s electrocardiography (ECG) 
is shown, and right hemi block and RV strain is obvious. 
Echocardiography showed cardiomyopathy.
growth, seizures due to hypocalcemia because of 
parathyroid disease); so, screening for endocrinopathy 
is suggested by measuring serum electrolytes, glucose, 
calcium, magnesium, plasma cortisol level, and thyroid 
function (2-4).
Patient report
Our patient was a 15 year-old girl. She was produced 
by cesarean section. Birth weight was 2800 g. She 
had jaundice with phototherapy, which was improved 
without complication. Growth and development 
were normal until 3 years of age; with the onset of 
hair loss and hypocalcemia, then, she was referred 
to pediatric endocrinologist, and after the diagnosis 
of hypoparathyroidism was treated with calcium and 
calcitriol. After that, growth disorder and hearing loss 
were detected. After further investigation, it was proved 
that the patient had already had a hearing deficit. She was 
hospitalized at the age of 8 with polyuria and polydipsia 
due to DKA (diabetic ketoacidosis), and the diagnosis 
of type 1 diabetes was confirmed. Insulin therapy was 
started afterwards. At the age of 12, ptosis together with 
retinitis pigmentosa was detected in both eyes, which 
caused a decrease in visual acuity level and consequently 
led to difficulty in walking because of poor vision.
Intelligence quotient (IQ) level was normal, but because 
of the slight hearing loss, the ability to understand 
content decreased. By the age of 12, she was suffering 
from muscle weakness in all four limbs.
In her family history, parents were relatives and her 
grandfather was suffering from diabetes mellitus (DM). 
Her siblings were in normal condition.
Physical examination
Blood pressure was about 120/80 mmHg; heart 
auscultation was normal; height was 140 cm; and weight 
was 38 kg. Force of muscles was estimated to be around 
3/5 and DTRs (deep tendon reflexes) decreased, but the 
muscle tone was normal. Eye movements were slow and 
palsy of 3rd nerve, extraocular palsy, and bilateral ptosis 
were obvious (Figure 1). 
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Fig 3. Brain CT scan shows bilateral calcification in basal ganglia, periventricular demyelination and mild dilatation 
of lateral ventricles.
Fig 4. T2-weighted views of brain MRI shows high-intencity signals in periventricular white matter and midbrain
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The brain CT scan showed calcification in basal ganglia, periventricular demyelinization, and mild dilatation of lateral 
ventricles (Figure 3).
Fig 2. ECG of the patient that shows right hemi-block
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al. described myopia, nystagmus vestibular disorders, 
myopathy, nystagmus, and encephalopathy (11). Chu et 
al. described the brain signs in brain MRI as subcortical 
white matter involvement and other brain structures, such 
as brain stem, globus pallidus, and thalamus. (12) In our 
patient, calcifications in basal ganglia, periventricular 
demyelinization, and mild dilatation of lateral ventricles 
were obvious. Altunbaşak et al. in 1998 described 
cardiac involvement as the key symptom of disease, 
which may lead to death (13). Chawla et al. noted 
prolonged PR or QT intervals and sinus dysrhythmia 
(14). Muscle biopsy may reveal ragged red fibers and 
muscle histochemistry can determine deficiency of 
cytochrome c oxidase (16). Histological evaluation was 
not performed due to patient’s disagreement. ACC/AHA 
guideline in 2002 recommended pacemaker placement 
in neuromuscular diseases like Kearns-Sayre syndrome, 
even in symptom free patients (15). Also, folinic acid can 
cause clinical and radiological improvement, especially 
in leukoencephalopathy (16).
In conclusion, Kearns-Sayre syndrome is a 
mitochondrial disease with mortal cardiac disorders 
before 20 years old and visual disturbance associated with 
endocrinopathy and myopathy. According to our report, 
it is important that each youth with endocrinopathy to be 
suspected of having mitochondrial disorders. 
References
1. Ashizawa T, Subramony SH. What is Kearns-Sayer 
syndrome after all? Arch Neurol 2001;58(7):1053-4.
2. Barragan-Campos HM, Vallee JN, Lo D, Barrera-Ramirez 
CF, Argote-Greene M, Sanchez-Guerrero J, et al. Brain 
magnetic resonance imaging findings in patients with 
mitochondrial cytopathies. Arch Neurol 2005;62(5):737–
42.
3. Amemiya S, Hamamoto M, Goto Y, Komaki H, Nishino 
I, Nonaka I, et al. Psychosis and progressive dementia: 
presenting features of a mitochondriopathy. Neurology 
2000;55(4):600-1.
4. Katsanos KH, Pappas CJ, Patsouras D, Michalis LK, 
Kitsios G, Elisaf M, et al. Alarming atrioventricular block 
and mitral valve prolapse in the Kearns-Sayer syndrome. 
Int J Cardiol 2002;83(2):179-81. 
In T2-weighted and FLAIR (fluid-attenuated inversion 
recovery) views of brain MRI, abnormal brain signals 
from white matter and basal ganglia and midbrain were 
apparent, which are suggested for metabolic diseases or 
mitochondrial neuropathies (Figure 4).
Her speech was not eloquent. The patients’ audiometry 
showed sensorineural deafness.
She could rely on herself for doing some of her daily 
routines. She was advised to undergo treatment with 
cardiac pacemaker for heart block, which can prevent 
sudden death. She was recommended to receive 
coenzyme Q10 (Ubiquinone) and vitamin supplements 
to support heart function and provide antioxidant 
protection.
We encouraged her to follow her treatment better to 
control her DM 1 and hypoparathyroidism.
Discussion
Inheritance pattern of Kearns-Sayre syndrome may be 
sporadic, autosomal dominant, or due to mutations in 
mtDNA (mitochondrial genome) that is inherited almost 
exclusively through the maternal lineage. Its prevalence 
is 1 to 3 cases per 100,000 people (5). The risk of 
maternal transmission has been estimated to be 1 in 24. 
The deletions vary in size and location. Amounts of 
deleted and wild-type mtDNA determine the phenotype. 
There is no sex or racial predilection. The onset is 
usually before 20 years of age (6). Bosbach et al.’s study 
in Germany showed that in patients with Kearns-Sayre 
syndrome, intelligence level is relatively normal and 
visual perception is impaired, and its progress indicates 
the impairment of prefrontal cortex (7).
Cardiac complications are very common in patients with 
Kearns-Sayre syndrome. Berenberg et al. described most 
common cardiac features. In their study, the most common 
causes of death were cardiomyopathy and sudden cardiac 
death (8). Right Ventricle Strain and right hemi-block 
was evident in our patient’s ECG. In some patients, 
mitral or tricuspid valve prolapse was seen as well. AV 
block incidence is high in Kearns-Sayre syndrome, and 
most of the patients need pacemakers. Welzingin et 
al. in 2008 described Kearns-Sayre as a mitochondrial 
encephalopathy with increased level of CSF protein 
content (9). Berio et al. (10) found out the lack of growth 
hormone in Kearns-Sayre syndrome and Schmiedel et 
Hypoparathyroidism as the First Manifestation of Kearns-Sayre Syndrome: A Case Report
57Iran J Child Neurol. 2013 Autumn Vol 7 No 4 
5. Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri 
R, Tiveron C, et al. Loss of ETHE1, a mitochondrial 
dioxygenase, causes fatal sulfide toxicity in ethylmalonic 
encephalopathy. Nat Med 2009;15(2):200–5.
6. Chinnery PF, DiMauro S, Shanske S, Schon EA, Zeviani 
M, Mariotti C, et al. Risk of developing a mitochondrial 
DNA deletion disorder. Lancet 2004;364(9434):592–6.
7. Bosbach S, Kornblum C, Schröder R, Wagner M. Executive 
and visuospatial deficits in patients with chronic 
progressive external ophthalmoplegia and Kearns-Sayer 
syndrome. Brain 2003;126(Pt 5):1231-40.
8. Berenberg RA, Pellock JM, DiMauro S, Schotland DL, 
Bonilla E, Eastwood A, et al. Lumping or splitting? 
“Ophthalmoplegia-plus” or Kearns-Sayer syndrome? 
Ann Neurol 1977;1(1):37-54.
9. Welzing L, von Kleist-Retzow JC, Kribs A, Eifinger F, 
Huenseler C, Sreeram N. Rapid development of life 
threatening complete atrioventricular block in Kearns-
Sayer syndrome. Eur J Pediatr 2009;168(6):757-9. 
10. Berio A, Piazzi A. Kearns-Sayer syndrome with GH 
deficiency. Pediatr Med Chir 2000;22:43-6.
11. Schmiedel J, Jackson S, Schäfer J, Reichmann H. 
Mitochondrial cytopathies. J Neurol 2003;250(3):267-77. 
12. Chu BC, Terae S, Takahashi C, Kikuchi Y, Miyasaka 
K, Abe S, et al. MRI of the brain in the Kearns-
Sayer syndrome: report of four cases and a review. 
Neuroradiology 1999;41(10):759-64. 
13. Altunbaşak S, Bingöl G, Ozbarlas N, Akçören Z, Hergüner 
O. Kearns-Sayer syndrome. A case report. Turk J Pediatr 
1998;40(2):255-9.
14. Chawla S, Coku J, Forbes T, Kannan S. Kearns-Sayer 
syndrome presenting as complete heart block. Pediatr 
Cardiol 2008;29(3):659-62. 
15. Gregoratos G, Abrams J, Epstein AE, Freedman RA, 
Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 
guideline update for implantation of cardiac pacemakers 
and antiarrhythmia devices: summary article: a report 
of the American College of Cardiology/American Heart 
Association Task Force on Practice Guidelines (ACC/
AHA/NASPE Committee to Update the 1998 Pacemaker 
Guidelines). Circulation 2002;106(16):2145-61.
16. Basu AP, Posner E, McFarland R, Turnbull DM. Kearn-
sayre syndrome. Medscape reference. Feb 4, 2010. http://
emedicine.medscape.com/article/950897.
Hypoparathyroidism as the First Manifestation of Kearns-Sayre Syndrome: A Case Report
